In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.
作者信息
Steinbach William J, Perfect John R, Schell Wiley A, Walsh Thomas J, Benjamin Daniel K
机构信息
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.
出版信息
Antimicrob Agents Chemother. 2004 Sep;48(9):3217-25. doi: 10.1128/AAC.48.9.3217-3225.2004.
Abstract
摘要
相似文献
1
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.
Antimicrob Agents Chemother. 2004 Sep;48(9):3217-25. doi: 10.1128/AAC.48.9.3217-3225.2004.
2
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9.
3
Efficacy of caspofungin against Aspergillus terreus.
Antimicrob Agents Chemother. 2005 Dec;49(12):5133-5. doi: 10.1128/AAC.49.12.5133-5135.2005.
4
Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
Med Mycol. 2015 Aug;53(6):630-5. doi: 10.1093/mmy/myv027. Epub 2015 May 14.
5
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
J Antimicrob Chemother. 2003 Apr;51(4):913-9. doi: 10.1093/jac/dkg185. Epub 2003 Mar 13.
6
A nonlethal murine cutaneous model of invasive aspergillosis.
Methods Mol Biol. 2012;845:569-82. doi: 10.1007/978-1-61779-539-8_42.
7
Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
J Antimicrob Chemother. 2014 Nov;69(11):3148-55. doi: 10.1093/jac/dku241. Epub 2014 Jul 8.
8
Antifungal therapy of murine Aspergillus terreus infection.
Antimicrob Agents Chemother. 2004 Oct;48(10):3715-9. doi: 10.1128/AAC.48.10.3715-3719.2004.
9
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
Drug Resist Updat. 2005 Dec;8(6):344-58. doi: 10.1016/j.drup.2006.01.001. Epub 2006 Feb 20.
10
Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Clin Microbiol Infect. 2012 Feb;18(2):E24-6. doi: 10.1111/j.1469-0691.2011.03714.x. Epub 2011 Nov 30.
引用本文的文献
1
Deciphering section in model: a clade-specific pathogenicity characterization.
Microbiol Spectr. 2025 May 6;13(5):e0257624. doi: 10.1128/spectrum.02576-24. Epub 2025 Mar 17.
2
and the Interplay with Amphotericin B: from Resistance to Tolerance?
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0227421. doi: 10.1128/aac.02274-21. Epub 2022 Mar 7.
3
Complete genome sequence of lovastatin producer Aspergillus terreus ATCC 20542 and evaluation of genomic diversity among A. terreus strains.
Appl Microbiol Biotechnol. 2021 Feb;105(4):1615-1627. doi: 10.1007/s00253-021-11133-0. Epub 2021 Jan 30.
4
Resistance mechanism and proteins in species against antifungal agents.
Mycology. 2019 Feb 6;10(3):151-165. doi: 10.1080/21501203.2019.1574927. eCollection 2019.
5
The Genome of a Thermo Tolerant, Pathogenic Albino .
Front Microbiol. 2018 Aug 14;9:1827. doi: 10.3389/fmicb.2018.01827. eCollection 2018.
6
Triazole Resistance in Aspergillus spp.: A Worldwide Problem?
J Fungi (Basel). 2016 Jul 4;2(3):21. doi: 10.3390/jof2030021.
7
Pediatric Invasive Aspergillosis.
J Fungi (Basel). 2016 Jun 13;2(2):19. doi: 10.3390/jof2020019.
8
Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Medicine (Baltimore). 2017 Dec;96(49):e8841. doi: 10.1097/MD.0000000000008841.
9
Spondylodiscitis Due to Aspergillus terreus in an Immunocompetent Host: Case Report and Literature Review.
Mycopathologia. 2016 Aug;181(7-8):575-81. doi: 10.1007/s11046-016-0007-6. Epub 2016 Apr 2.
10
Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.
PLoS One. 2015 Mar 17;10(3):e0118997. doi: 10.1371/journal.pone.0118997. eCollection 2015.
本文引用的文献
1
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Clin Infect Dis. 2004 Jul 15;39(2):192-8. doi: 10.1086/421950. Epub 2004 Jun 28.
2
Epidemiology of Aspergillus terreus at a university hospital.
J Clin Microbiol. 2003 Dec;41(12):5525-9. doi: 10.1128/JCM.41.12.5525-5529.2003.
3
Clinical, bacteriological and mycological findings in post-operative ear cavities.
J Laryngol Otol. 1962 Jan;76:12-21. doi: 10.1017/s0022215100058953.
4
SUBCUTANEOUS INFECTION DUE TO ASPERGILLUS TERREUS.
J Clin Pathol. 1964 May;17(3):251-3. doi: 10.1136/jcp.17.3.251.
5
An outbreak of fungal infections of postoperative aural cavities.
J Laryngol Otol. 1962 Jan;76:1-11. doi: 10.1017/s0022215100058941.
6
The significance of mycotic infection in the aetiology of otitis externa.
J Laryngol Otol. 1961 Feb;75:167-70. doi: 10.1017/s0022215100057613.
7
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
J Clin Microbiol. 2003 Aug;41(8):3623-6. doi: 10.1128/JCM.41.8.3623-3626.2003.
8
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9.
9
In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
J Antimicrob Chemother. 2003 Jun;51(6):1419-22. doi: 10.1093/jac/dkg245. Epub 2003 Apr 25.
10
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
J Antimicrob Chemother. 2003 Apr;51(4):913-9. doi: 10.1093/jac/dkg185. Epub 2003 Mar 13.
Zotero 插件